 In the European Union, a registration application was filed in 2001, but in 2007 there was still no definitive agreement regarding the legal status of novaluron.Member states of the European Union were allowed to award temporary permits for products based on novaluron.On April 4, 2012, a decision was disclosed which discontinued permits for the use of novaluron, to be executed on October 3.